The brain has a waste-disposal system that clears away junk proteins that contribute to the development of dementia and ...

Sage Therapeutics said on Tuesday it would stop developing its experimental drug, dalzanemdor, for Alzheimer's disease after ...

Microglia are the brain's resident immune cells. Their job is to patrol the brain's blood vessels looking for invading ...

Bristol-Myers’ newly approved schizophrenia treatment might be coming full circle.

Walk for hope. Walk for a loved one. Walk for a cure. Late October, nearly a hundred participants across 19 teams in LaGrange ...

Researchers have found that the drug dronabinol — a synthetic version of the psychoactive THC compound in cannabis — helped ...

What I really hope for is to be functional and continue to do as many things as I can possibly do,” says Virginia Arey of ...

New research shows astrocytes can remove Alzheimer’s-related amyloid-beta via autophagy, offering a promising new direction ...

An Alzheimer’s treatment from idea to market can take up to 20 years. After a long hiatus, the U.S. Food and Drug Administration (FDA) has approved three new drugs to treat Alzheimer’s since June 2021 ...

Scientists have developed a novel peptide that could potentially revolutionize the treatment of Alzheimer's disease and other neurodegenerative disorders known as tauopathies.

The annual Alzheimer Calgary Walk and Run is set for Sunday (Oct. 13) which will start at Prince's Island Park. Registration ...

The money will support the development of Alzheimer's tests specific to tau tangles, the abnormal proteins that form inside ...